ALGS vs OKE · rev $3.6M vs P/E 15, rev $21.70B
Aligos Therapeutics Inc (ALGS) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
ALGS currently screens at market cap $44.1M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the ALGS and OKE stock pages for the full models.
Not investment advice.